Fig. 3From: A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions using 18F-FES PET/CT imagingGeometric mean elacestrant plasma concentrations over time (N = 16). Vertical bars indicate standard error of the meanBack to article page